173 related articles for article (PubMed ID: 3117159)
1. Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD.
Dodd GW; Ibbertson HK; Fraser TR; Holdaway IM; Wattie D
Br J Radiol; 1987 Sep; 60(717):849-60. PubMed ID: 3117159
[TBL] [Abstract][Full Text] [Related]
2. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
[TBL] [Abstract][Full Text] [Related]
3. Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate.
Anderson DC; O'Driscoll JB; Buckler HM; Cantrill J; Brown JD
Br J Radiol; 1988 Nov; 61(731):996-1001. PubMed ID: 3208019
[TBL] [Abstract][Full Text] [Related]
4. Radiological demonstration of healing in Paget's disease of bone treated with APD.
Vellenga CJ; Mulder JD; Bijvoet OL
Br J Radiol; 1985 Sep; 58(693):831-7. PubMed ID: 3842289
[TBL] [Abstract][Full Text] [Related]
5. Dynamic radiologic patterns of Paget's disease of bone.
Maldague B; Malghem J
Clin Orthop Relat Res; 1987 Apr; (217):126-51. PubMed ID: 3103963
[TBL] [Abstract][Full Text] [Related]
6. Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.
Patel U; Gallacher SJ; Boyle IT; McKillop JH
Nucl Med Commun; 1990 Nov; 11(11):747-60. PubMed ID: 2126078
[TBL] [Abstract][Full Text] [Related]
7. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
Miravet L; Kuntz D
Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
[TBL] [Abstract][Full Text] [Related]
8. Quantitative bone scintigraphy in Paget's disease treated with APD.
Vellenga CJ; Pauwels EK; Bijvoet OL; Harinck HI; Frijlink WB
Br J Radiol; 1985 Dec; 58(696):1165-72. PubMed ID: 3842627
[TBL] [Abstract][Full Text] [Related]
9. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Jaeger P; Bischoff-Delaloye A; Burckhardt P
Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
[TBL] [Abstract][Full Text] [Related]
10. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategy in Paget's disease of bone.
Meunier PJ; Vignot E
Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
Papapoulos SE; Frölich M
J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
[TBL] [Abstract][Full Text] [Related]
13. Healing of lytic Paget bone disease with diphosphonate therapy.
Murphy WA; Whyte MP; Haddad JG
Radiology; 1980 Mar; 134(3):635-7. PubMed ID: 7355210
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy of Paget's disease of bone with EHDP.
Siris ES; Canfield RE; Jacobs TP; Baquiran DC
Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
Mautalen CA; Gonzalez D; Ghiringhelli G
Bone; 1985; 6(6):429-32. PubMed ID: 4096879
[TBL] [Abstract][Full Text] [Related]
16. Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone.
Devogelaer JP; Malghem J; Stasse P; Nagant de Deuxchaisnes C
Bone; 1997 Mar; 20(3):259-61. PubMed ID: 9071477
[TBL] [Abstract][Full Text] [Related]
17. Diphosphonate therapy of paget's disease of bone.
Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
[TBL] [Abstract][Full Text] [Related]
18. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
Dewis P; Prasad BK; Anderson DC; Willets S
Ann Rheum Dis; 1985 Jan; 44(1):34-8. PubMed ID: 3918513
[TBL] [Abstract][Full Text] [Related]
20. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
